Menopause & HRT, honestly — past the old scare

Menopause care was set back by two decades of fear after one misread trial. The honest headline: for many women who start near menopause, hormone therapy has a favourable benefit-risk for symptoms and bone — a real update from the old blanket warnings, with genuine nuances that still matter.

What happened — and what changed

Menopause is when the ovaries wind down and oestrogen falls, often bringing hot flushes, disturbed sleep, mood changes and, over time, bone loss and higher cardiovascular risk. Hormone therapy (HRT, also called MHT) replaces some of that oestrogen (with a progestogen if you have a uterus).

In 2002 a big trial (the WHI) reported increased risks and was stopped early, and prescribing collapsed worldwide. But that trial studied mostly older women, many years past menopause. Re-analysis reshaped the picture around when therapy is started — the "timing hypothesis".

What the evidence now supports

Timing changes the calculus.

• The original scare came from an older population — The WHI found net harms partly because it enrolled mostly women well past menopause, in whom starting hormones later carries more cardiovascular and clot risk. Applied as a blanket rule to all women, it caused decades of under-treatment. (established)
• Started near menopause, benefit-risk is often favourable — The menopause societies now hold that for healthy women under ~60 or within ~10 years of their last period, and without specific contraindications, hormone therapy has a favourable balance for treating symptoms and protecting bone. That’s a substantial, evidence-based shift. (emerging)

The honest nuances

• It’s individual, not one-size-fits-all — Personal and family history (breast cancer, clots, heart disease), the type and route of hormones (patches vs pills differ on clot risk), and your symptoms all change the decision. This is a conversation with a knowledgeable clinician, not a yes/no. (note)
• HRT is for symptoms and bone — not a general anti-ageing drug — It reliably treats hot flushes and protects bone, and may help some cardiovascular markers when started early. But taking it purely as a longevity or "stay young" intervention outruns the evidence. (note)
• Non-hormonal options exist too — For those who can’t or prefer not to use hormones, there are effective non-hormonal treatments for symptoms, plus the foundations (exercise, strength training for bone, sleep, alcohol moderation). (note)

What we still don’t know

• The exact long-term balance when started early The timing hypothesis is well supported for symptoms and bone; precise long-term cardiovascular and cancer effects of early-start therapy are still being refined.
• The best duration How long to continue therapy is individualised and not settled by a single rule.

Key terms

• Menopause The point when periods have stopped for 12 months as the ovaries wind down and oestrogen falls; the years around it bring symptoms.
• HRT / MHT Hormone (or menopausal hormone) therapy — replacing some oestrogen, with a progestogen if you have a uterus, to treat symptoms and protect bone.
• Timing hypothesis The evidence that hormone therapy’s benefit-risk is more favourable when started near menopause than years later.
• WHI The Women’s Health Initiative — the 2002 trial whose early stop, in an older population, caused decades of HRT fear.
• Progestogen A hormone given alongside oestrogen (if you have a uterus) to protect the womb lining.